U.S. lawmakers ramp up scrutiny of FDA following agency’s approval of controversial Alzheimer’s drug
By
Alicia Lasek
Sep 07, 2021
The FDA is being asked to help explain how Aduhelm (aducanumab) met accelerated approval criteria when so many experts — including internal advisers — have flagged insufficient safety and efficacy...
NAMS updates guidance for managing osteoporosis in older women
By
Alicia Lasek
Sep 07, 2021
Lifelong treatment is required to keep osteoporosis under control in post-menopausal women, and hormone therapy is often the best choice to prevent further bone loss, according to the North American Menopause...
Clinical briefs for Tuesday, Sept. 7
By
Alicia Lasek
Sep 07, 2021
Study of 6.2 million patients finds no serious health effects for Pfizer, Moderna COVID shots … Eli Lilly’s COVID antibody combo approved again for use in all 50 states … Risk of ‘long COVID’...
Prescribing off-label COVID boosters may put providers at legal risk: report
By
Alicia Lasek
Sep 06, 2021
Clinicians who provide additional COVID-19 shots to fully vaccinated patients may be at risk for legal claims if they prescribe the doses outside of current federal guidelines, CDC says.
COVID vaccine protection drops by 80 percent in 6 months among nursing home residents: study
By
Alicia Lasek
Sep 03, 2021
Vaccinated staff members had a similar six-month decrease in immunity levels, investigators say. The data may support recommendations for vaccine booster shots, they contend.
SNF residents avoid repeat hospitalization with nurse-led heart failure program
By
Alicia Lasek
Sep 03, 2021
Sixty days after admission, patients in the disease management program had a lower composite rate of rehospitalization, ED visits or mortality when compared with their peers who had usual care. The program...
Clinical briefs for Friday, Sept. 3
By
Alicia Lasek
Sep 03, 2021
New COVID test shortages and delays evoke comparisons to earlier pandemic days … COVID long-haulers at risk for substantial kidney decline … Half of COVID survivors have at least 1 symptom a year later:...
Pfizer, Merck start testing COVID prevention pills in late-stage trials
By
Alicia Lasek
Sep 02, 2021
The drugs, each given orally as a pill, would provide an unprecedented COVID-19 preventive medication option if brought to market.
Orthostatic intolerance common in post-acute patients, signaling need for clinical workup
By
Alicia Lasek
Sep 02, 2021
Older rehabilitation patients should be assessed for symptoms of orthostatic intolerance upon admission, a new study suggests.
FDA warns of heart-related events for arthritis drug Xeljanz and others in its class
By
Alicia Lasek
Sep 02, 2021
The agency is requiring a warning label on the arthritis and ulcerative colitis drugs Xeljanz and Xeljanz XR (tofacitinib) and two other drugs in this class, citing an increased risk of adverse health...